Articles by Peter K. Watler, PhD - BioPharm International

Articles by Peter K. Watler, PhD

New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs

Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.
Jan 2, 2010
By: Eluemuno R. Blyden, PhD, Peter K. Watler, PhD

Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.